Delta Air Lines (DAL)

Total Liabilities

$63.54B

Quarterly · Period ending: · USD

DAL logo

DAL Total Liabilities

Latest reported$63.54B
DAL Quarterly Total Liabilities ($2.48B → $63.54B)
High-resolution chart · PNG

DAL total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Delta Air Lines Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
63,535,000,000
64,506,000,000
64,055,000,000
60,432,000,000
60,801,000,000
60,955,000,000
61,895,000,000
60,079,000,000
61,722,000,000
62,811,000,000
63,818,000,000
62,539,000,000
64,021,000,000
65,397,000,000
66,874,000,000
65,706,000,000
68,006,000,000
70,994,000,000
70,757,000,000
68,572,000,000
70,177,000,000
74,028,000,000
72,601,000,000
70,462,000,000
75,719,000,000
63,571,000,000
54,429,000,000
49,174,000,000
48,151,000,000
48,560,000,000
48,930,000,000
46,579,000,000
41,299,000,000
42,940,000,000
41,521,000,000
41,141,000,000
37,927,000,000
38,336,000,000
38,514,000,000
38,974,000,000
38,438,000,000
39,824,000,000
42,090,000,000
42,284,000,000
43,301,000,000
43,218,000,000
44,706,000,000
45,192,000,000
39,644,000,000
39,988,000,000
40,526,000,000
40,609,000,000
45,860,000,000
46,956,000,000
47,011,000,000
46,681,000,000
44,400,000,000
45,855,000,000
45,200,000,000
44,895,000,000
41,814,000,000
43,093,000,000
43,123,000,000
42,291,000,000
42,438,000,000
43,610,000,000
44,267,000,000
43,544,000,000
43,953,000,000
43,500,000,000
43,876,000,000
44,210,000,000
23,207,000,000
23,930,000,000
22,804,000,000
22,310,000,000
23,025,000,000
24,262,000,000
33,487,000,000
33,215,000,000
34,552,000,000
34,603,000,000
32,221,000,000
29,934,000,000
28,678,000,000
28,546,000,000
28,366,000,000
27,597,000,000
27,103,000,000
27,127,000,000
27,202,000,000
26,598,000,000
25,264,000,000
24,878,000,000
23,960,000,000
23,827,000,000
21,192,000,000
20,886,000,000
20,294,000,000
19,836,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.